Brands
Discover
Events
Newsletter
More

Follow Us

twitterfacebookinstagramyoutube
Youtstory

Brands

Resources

Stories

General

In-Depth

Announcement

Reports

News

Funding

Startup Sectors

Women in tech

Sportstech

Agritech

E-Commerce

Education

Lifestyle

Entertainment

Art & Culture

Travel & Leisure

Curtain Raiser

Wine and Food

YSTV

ADVERTISEMENT
Advertise with us

PharmEasy to hire over 200 engineers for upcoming development centres in Hyderabad, Pune, and NCR

The company is building a larger ecosystem to solve outpatient healthcare challenges, bridging the gap in the healthcare industry, PharmEasy said in a statement.

PharmEasy to hire over 200 engineers for upcoming development centres in Hyderabad, Pune, and NCR

Tuesday September 14, 2021 , 2 min Read

Leading e-pharmacy firm Pharmeasy has said it is looking to hire over 200 engineers for its soon-to-be-launched development centres in Hyderabad, Pune, and NCR region.


The company is building a larger ecosystem to solve outpatient healthcare challenges, bridging the gap in the healthcare industry, PharmEasy said in a statement.

"Our team is focussed on building the healthcare ecosystem for a modern and digital-first India, to fulfil our mission; simplifying healthcare and impacting lives. We are looking for exceptionally talented and motivated individuals who are committed to this mission," PharmEasy Co-Founder Hardik Dedhia said.

As technology is a key enabler, the company is planning to strengthen its hiring across technological functions, PharmEasy said.

PharmEasy

"The new facilities will serve as a significant hub for driving development and innovation. Ahead of the opening of the new centres, PharmEasy will provide opportunities for inquisitive technology professionals across product and engineering in different locations from all over the country, with a flexible work model," PharmEasy CTO Abhinav Yajurvedi said.


In May 2021, the e-pharmacy startup had acquired Medlife for an undisclosed amount in a deal that skyrocketed its position to India's largest medicine delivery platform.


In June 2021, PharmEasy's parent company — API Holdings Limited — announced it had signed definitive documents to acquire 66.1 percent stake in Thyrocare Technologies Ltd (Thyrocare) from Dr A Velumani and affiliates at a price of Rs 1,300 per share, aggregating to Rs 4,546 crore.


(Disclaimer: Additional background information has been added to this PTI copy for context)


Edited by Megha Reddy